ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
9.83
+0.31 (3.26%)
At close: Aug 13, 2025, 4:00 PM
9.75
-0.08 (-0.81%)
After-hours: Aug 13, 2025, 7:15 PM EDT
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $837.75 million as of August 13, 2025. Its market cap has increased by 4.42% in one year.
Market Cap
837.75M
Enterprise Value
557.50M
1-Year Change
4.42%
Ranking
Category
Stock Price
$9.83
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $837.75M, an increase of 12.91%. That is a compound annual growth rate of 2.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 811.33M | 42.47% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | 1.24B | 67.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 582.44B |
| Johnson & Johnson | 417.97B |
| AbbVie | 354.21B |
| UnitedHealth Group | 241.70B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 227.34B |
| Novo Nordisk | 223.00B |